94 related articles for article (PubMed ID: 30310055)
1. Systematic review and integrated analysis of prognostic gene signatures for prostate cancer patients.
An Y; Lu W; Li S; Lu X; Zhang Y; Han D; Su D; Jia J; Yuan J; Zhao B; Tu M; Li X; Wang X; Fang N; Ji S
Discov Oncol; 2023 Dec; 14(1):234. PubMed ID: 38112859
[TBL] [Abstract][Full Text] [Related]
2. Master Transcription Factor Reprogramming Unleashes Selective Translation Promoting Castration Resistance and Immune Evasion in Lethal Prostate Cancer.
Santasusagna S; Zhu S; Jawalagatti V; Carceles-Cordon M; Ertel A; Garcia-Longarte S; Song WM; Fujiwara N; Li P; Mendizabal I; Petrylak DP; Kelly WK; Reddy EP; Wang L; Schiewer MJ; Lujambio A; Karnes J; Knudsen KE; Cordon-Cardo C; Dong H; Huang H; Carracedo A; Hoshida Y; Rodriguez-Bravo V; Domingo-Domenech J
Cancer Discov; 2023 Dec; 13(12):2584-2609. PubMed ID: 37676710
[TBL] [Abstract][Full Text] [Related]
3. Dysbindin Domain-Containing 1 in Prostate Cancer: New Insights into Bioinformatic Validation of Molecular and Immunological Features.
Tram VTN; Khoa Ta HD; Anuraga G; Dung PVT; Xuan DTM; Dey S; Wang CY; Liu YN
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569304
[TBL] [Abstract][Full Text] [Related]
4. MiR-182 Is Upregulated in Prostate Cancer and Contributes to Tumor Progression by Targeting MITF.
Stafford MYC; McKenna DJ
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768146
[TBL] [Abstract][Full Text] [Related]
5. The role of
Cheng L; Zou X; Wang J; Zhang J; Mo Z; Huang H
Front Surg; 2022; 9():1117307. PubMed ID: 36713654
[TBL] [Abstract][Full Text] [Related]
6.
Valcarcel-Jimenez L; Rogerson C; Yong C; Schmidt C; Yang M; Cremades-Rodelgo M; Harle V; Offord V; Wong K; Mora A; Speed A; Caraffini V; Tran MGB; Maher ER; Stewart GD; Vanharanta S; Adams DJ; Frezza C
Sci Adv; 2022 Oct; 8(42):eabq8297. PubMed ID: 36269833
[TBL] [Abstract][Full Text] [Related]
7. Clinical, Virological and Immunological Subphenotypes in a Cohort of Early Treated HIV-Infected Children.
Domínguez-Rodríguez S; Tagarro A; Foster C; Palma P; Cotugno N; Zicari S; Ruggiero A; de Rossi A; Dalzini A; Pahwa S; Rinaldi S; Nastouli E; Marcelin AG; Dorgham K; Sauce D; Gartner K; Rossi P; Giaquinto C; Rojo P
Front Immunol; 2022; 13():875692. PubMed ID: 35592310
[TBL] [Abstract][Full Text] [Related]
8. Derivation and Application of Molecular Signatures to Prostate Cancer: Opportunities and Challenges.
Doultsinos D; Mills IG
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33525365
[TBL] [Abstract][Full Text] [Related]
9. Microphthalmia-Associated Transcription Factor-Dependent Melanoma Cell Adhesion Molecule Activation Promotes Peritoneal Metastasis of Ovarian Cancer.
Kitami K; Yoshihara M; Koya Y; Sugiyama M; Iyoshi S; Uno K; Mogi K; Tano S; Fujimoto H; Nawa A; Kikkawa F; Kajiyama H
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371469
[TBL] [Abstract][Full Text] [Related]
10. Progression of the role of CRYAB in signaling pathways and cancers.
Zhang J; Liu J; Wu J; Li W; Chen Z; Yang L
Onco Targets Ther; 2019; 12():4129-4139. PubMed ID: 31239701
[TBL] [Abstract][Full Text] [Related]
11. MiRNA-671-5p Promotes prostate cancer development and metastasis by targeting NFIA/CRYAB axis.
Zhu Z; Luo L; Xiang Q; Wang J; Liu Y; Deng Y; Zhao Z
Cell Death Dis; 2020 Nov; 11(11):949. PubMed ID: 33144585
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional network modulated by the prognostic signature transcription factors and their long noncoding RNA partners in primary prostate cancer.
Jiang M; Cheng Y; Wang D; Lu Y; Gu S; Wang C; Huang Y; Li Y
EBioMedicine; 2021 Jan; 63():103150. PubMed ID: 33279858
[TBL] [Abstract][Full Text] [Related]
13. Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma.
Fernández-Barral A; Orgaz JL; Baquero P; Ali Z; Moreno A; Tiana M; Gómez V; Riveiro-Falkenbach E; Cañadas C; Zazo S; Bertolotto C; Davidson I; Rodríguez-Peralto JL; Palmero I; Rojo F; Jensen LD; del Peso L; Jiménez B
Neoplasia; 2014 Jun; 16(6):529-42. PubMed ID: 25030625
[TBL] [Abstract][Full Text] [Related]
14. Melanocytes and the microphthalmia transcription factor network.
Steingrímsson E; Copeland NG; Jenkins NA
Annu Rev Genet; 2004; 38():365-411. PubMed ID: 15568981
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer.
Valcarcel-Jimenez L; Macchia A; Martín-Martín N; Cortazar AR; Schaub-Clerigué A; Pujana-Vaquerizo M; Fernández-Ruiz S; Lacasa-Viscasillas I; Santos-Martin A; Loizaga-Iriarte A; Unda-Urzaiz M; Hermanova I; Astobiza I; Graupera M; Starkova J; Sutherland J; Barrio R; Aransay AM; Carracedo A; Torrano V
Cell Death Dis; 2018 Oct; 9(10):1041. PubMed ID: 30310055
[TBL] [Abstract][Full Text] [Related]
16. SOX5 is involved in balanced MITF regulation in human melanoma cells.
Kordaß T; Weber CE; Oswald M; Ast V; Bernhardt M; Novak D; Utikal J; Eichmüller SB; König R
BMC Med Genomics; 2016 Feb; 9():10. PubMed ID: 26927636
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
